Cytomel
These highlights do not include all the information needed to use CYTOMEL safely and effectively. See full prescribing information for CYTOMEL. CYTOMEL (liothyronine sodium) tablets, for oral use Initial U.S. Approval: 1956
Approved
Approval ID
51452b31-ff68-4e0c-b982-c15502ebf1d3
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jul 24, 2019
Manufacturers
FDA
Pfizer Laboratories Div Pfizer Inc
DUNS: 134489525
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
liothyronine sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code60793-116
Application NumberNDA010379
Product Classification
M
Marketing Category
C73594
G
Generic Name
liothyronine sodium
Product Specifications
Route of AdministrationORAL
Effective DateJuly 24, 2019
FDA Product Classification
INGREDIENTS (1)
LIOTHYRONINE SODIUMActive
Quantity: 25 ug in 1 1
Code: GCA9VV7D2N
Classification: ACTIM
liothyronine sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code60793-115
Application NumberNDA010379
Product Classification
M
Marketing Category
C73594
G
Generic Name
liothyronine sodium
Product Specifications
Route of AdministrationORAL
Effective DateJuly 24, 2019
FDA Product Classification
INGREDIENTS (1)
LIOTHYRONINE SODIUMActive
Quantity: 5 ug in 1 1
Code: GCA9VV7D2N
Classification: ACTIM
liothyronine sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code60793-117
Application NumberNDA010379
Product Classification
M
Marketing Category
C73594
G
Generic Name
liothyronine sodium
Product Specifications
Route of AdministrationORAL
Effective DateJuly 24, 2019
FDA Product Classification
INGREDIENTS (1)
LIOTHYRONINE SODIUMActive
Quantity: 50 ug in 1 1
Code: GCA9VV7D2N
Classification: ACTIM